Jan Gajdziok

Prof. Jan Gajdziok

Department of Pharmaceutical Technology, Pharmaceutical Faculty, Masaryk University, Palackého třída 1946/1, 61200 Brno, Czech Republic
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
JEJan Elbl
Jan Elbl
JGJan Gajdziok
Jan Gajdziok
JKJan Kolarczyk
Jan Kolarczyk

11 June 2018 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
VPVeronika Pechová
Veronika Pechová
JGJan Gajdziok
Jan Gajdziok
JMJan Muselík
Jan Muselík
DVDavid Vetchý
David Vetchý

1 January 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
JGJan Gajdziok
Jan Gajdziok
Sylva HolešováSylva Holešová
Sylva Holešová
JSJan Stembirek
Jan Stembirek
EPErich Pazdziora
Erich Pazdziora
HLHana Landová
Hana Landová
DVDavid Vetchý
David Vetchý
Infectious stomatitis represents the most common oral cavity ailments. Current therapy is insufficiently effective because of the short residence time of topical liquid or semisolid medical formulations. An innovative application form based on bioadhesive polymers featuring prolonged residence time on the oral mucosa may be a solution to this challenge. This formulation consists of a mucoadhesive oral film with incorporated nanocomposite biomaterial that is able to release the drug directly at the target area. This study describes the unique approach of preparing mucoadhesive oral films from carmellose with incorporating a nanotechnologically modified clay mineral intercalated with chlorhexidine. The multivariate data analysis was employed to evaluate the influence of the formulation and process variables on the properties of the medical preparation. This evaluation was complemented by testing the antimicrobial and antimycotic activity of prepared films with the aim of finding the most suitable composition for clinical application. Generally, the best results were obtained with sample containing 20 mg of chlorhexidine diacetate carried by vermiculite, with carmellose in the form of nonwoven textile in its structure. In addition to its promising physicomechanical, chemical, and mucoadhesive properties, the formulation inhibited the growth ofStaphylococcusandCandida; the effect was prolonged for tens of hours.

17 May 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
BVBarbora Vraníková
Barbora Vraníková
JGJan Gajdziok
Jan Gajdziok
DVDavid Vetchý
David Vetchý
Liquisolid systems are an innovative dosage form used for enhancing dissolution rate and improvingin vivobioavailability of poorly soluble drugs. These formulations require specific evaluation methods for their quality assurance (e.g., evaluation of angle of slide, contact angle, or water absorption ratio). The presented study is focused on the preparation, modernin vitrotesting, and evaluation of differences of liquisolid systems containing varying amounts of a drug in liquid state (polyethylene glycol 400 solution of rosuvastatin) in relation to an aluminometasilicate carrier (Neusilin US2). Liquisolid powders used for the formulation of final tablets were prepared using two different methods: simple blending and spraying of drug solution onto a carrier in fluid bed equipment. The obtained results imply that the amount of liquid phase in relation to carrier material had an effect on the hardness, friability, and disintegration of tablets, as well as their height. The use of spraying technique enhanced flow properties of the prepared mixtures, increased hardness values, decreased friability, and improved homogeneity of the final dosage form.

1 April 2014 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
DVDavid Vetchý
David Vetchý
HLHana Landová
Hana Landová
JGJan Gajdziok
Jan Gajdziok
PDPetr Doležel
Petr Doležel
ZDZdeněk Daněk
Zdeněk Daněk
JSJan Stembirek
Jan Stembirek

2 February 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
JKJakub Karas
Jakub Karas
SPSylvie Pavloková
Sylvie Pavloková
HHHana Hořavová
Hana Hořavová
JGJan Gajdziok
Jan Gajdziok
Inhalation is used for local therapy of the lungs and as an alternative route for systemic drug delivery. Modern powder inhalation systems try to target the required site of action/absorption in the respiratory tract. Large porous particles (LPPs) with a size >5 μm and a low mass density (usually measured as bulk or tapped) of <0.4 g/cm3 can avoid protective lung mechanisms. Their suitable aerodynamic properties make them perspective formulations for deep lung deposition. This experiment studied the effect of spray-drying process parameters on LPP properties. An experimental design of twelve experiments with a central point was realized using the Box–Behnken method. Three process parameters (drying temperature, pump speed, and air speed) were combined on three levels. Particles were formed from a D-mannitol solution, representing a perspective material for lung microparticles. The microparticles were characterized in terms of physical size (laser diffraction), aerodynamic diameter (aerodynamic particle sizer), morphology (SEM), and densities. The novelty and main goal of this research were to describe how the complex parameters of the spray-drying process affect the properties of mannitol LPPs. New findings can provide valuable data to other researchers, leading to the easy tuning of the properties of spray-dried particles by changing the process setup.